Efficacy and resistance of EGFR-TKIs for first-line treatment for compound EGFR mutations positive non-small cell lung cancer

Efficacy and resistance of EGFR-TKIs for first-line treatment for compound EGFR mutations positive non-small cell lung cancer

Objective To observe the characteristics of mutation patterns in patients with compound EGFR mutations in the same exon and their resistance to EGFR TKIs, and to explore the clinical features and survival benefits among these non-small cell lung cancer (NSCLC) patients. Methods The survival benefits...

Full description

Bibliographic Details
Main Authors: GUAN Xuhui, LIN Xiaocheng, YANG Jinji
Format: Article
Language:zho
Published: Editorial Office of Journal of Army Medical University 2022-12-01
Series:陆军军医大学学报
Subjects:
ompound mutations
tyrosine kinase inhnon-small cell lung cancer
epidermal growth factor receptor
egfr cibitor
Online Access:http://aammt.tmmu.edu.cn/Upload/rhtml/202208119.htm

Internet

http://aammt.tmmu.edu.cn/Upload/rhtml/202208119.htm

Similar Items